Ligand validation:5HHF

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 5HHF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HHF_FDA_C_606	75%	10%	0.125	0.959	2.82	1.47	23	12	2	0	100%	1
5HHF_FDA_D_605	65%	9%	0.141	0.942	2.78	1.77	22	13	3	0	100%	1
4U8P_FDA_B_601	93%	12%	0.086	0.98	2.5	1.64	19	10	0	0	100%	1
3UTF_FDA_B_511	86%	11%	0.106	0.975	2.69	1.59	25	9	0	0	100%	1
4U8O_FDA_B_601	85%	10%	0.119	0.984	2.73	1.57	22	9	0	0	100%	1
4WX1_FDA_C_601	85%	10%	0.104	0.968	2.7	1.63	24	10	0	0	100%	1
3UTH_FDA_B_511	85%	10%	0.108	0.972	2.66	1.64	23	10	0	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1
4MOF_FDA_A_801	100%	19%	0.04	0.983	1.62	1.84	14	15	1	0	100%	1
7AA2_FDA_A_701	100%	60%	0.043	0.986	0.69	0.83	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.